ARRY - アレイ・バイオファ―マ (Array BioPharma Inc.) アレイ・バイオファ―マ

 ARRYのチャート


 ARRYの企業情報

symbol ARRY
会社名 Array BioPharma Inc. (アレイ・バイオファ―マ)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 アレイ・バイオファーマ(Array BioPharma Inc.)は、癌に罹患した患者を治療するための標的化された小分子薬物の発見、開発、および商業化に焦点を当てた生物医薬品会社である。同社のプログラムには、約3種類のがん剤、ビニメチニブ、エンコラフェニブおよびセルメチニブ(AstraZeneca、PLCと提携)が含まれている。そのビニメチニブおよびエンコラフェニブは進行癌患者の第III相試験中であり、BRAF突然変異メラノーマ患者のビニメチニブと併用してエンコファニブを試験するCOLUMBUS試験を含み、BRAF V600E突然変異結腸直腸癌(BRAFm CRC)患者のビシメチニブおよびセツキシマブと組み合わせてエンコラフェニブを試験するBEACON CRC試験を開始した。そのセルメチニブは、癌のためのマイトジェン活性化プロテインキナーゼ(MEK)阻害剤であり、これは第III相試験中である。同社の先進的な臨床段階の薬剤には、Filanesib、ARRY-797、ASC08 / Danoprevir、Ipatasertib / GDC-0068、Motolimod / VTX-2337、LOXO-101、ONT-380 / ARRY-380、GDC-0575、GDC-0994およびARRY -382が含まれる。   アレイ・バイオファ―マは、米国のバイオ医薬品会社。主に癌患者の治療向け低分子薬の発見、開発、商業化に従事。全額出資の臨床段階の薬剤は、多発性骨髄腫のためのキネシンスピンドルタンパク質阻害剤ARRY-520、ラミンA / C関連の拡張型心筋症のためのp38阻害剤ARRY-79など。本社はコロラド州ボ―ルダ―。   Array Technologies is a leading global technology company providing tracker solutions and services for utility-scale solar energy projects as one of the world's largest manufacturers of ground-mounted systems. With efficient installation and terrain flexibility coupled with high reliability, durability, and performance, Array delivers a lower levelized cost of energy. The Company's focus on innovation, combined with its customer-centric approach, has helped achieve some of the industry's best returns. Array Technologies is headquartered in the United States with offices in Europe, Central America, and Australia.
本社所在地 3200 Walnut Street Boulder CO 80301 USA
代表者氏名 Carrie S. Cox キャリーS.コックス
代表者役職名 Chairman of the Board 取締役会会長
電話番号 +1 303-381-6600
設立年月日 35827
市場名 NASDAQ National Market System
ipoyear 2000年
従業員数 298人
url www.arraybiopharma.com
nasdaq_url https://www.nasdaq.com/symbol/arry
adr_tso
EBITDA EBITDA(百万ドル) -127.69100
終値(lastsale) 13.665
時価総額(marketcap) 2909574880.185
時価総額 時価総額(百万ドル) 3291.769
売上高 売上高(百万ドル) 173.76800
企業価値(EV) 企業価値(EV)(百万ドル) 2991.057
当期純利益 当期純利益(百万ドル) -147.34600
決算概要 決算概要 BRIEF: For the fiscal year ended 30 June 2018 Array Biopharma Inc revenues increased 15% to $173.8M. Net loss increased 26% to $147.3M. Revenues reflect Asia Pacific segment increase from $3.8M to $46.1M. Higher net loss reflects General and administrative increase of 49% to $58.5M (expense) Realized gains on investments and other decrease of 92% to $69K (income).

 ARRYのテクニカル分析


 ARRYのニュース

   Array Technologies Q1 2023 Earnings Preview  2023/05/08 21:37:16 Seeking Alpha
Array Technologies (ARRY) is scheduled to announce Q1 earnings results on Tuesday, May 9th, after market close.The consensus EPS Estimate is $0.04 and the consensus Revenue Estimate…
   Array Technologies Brings Solar Flare To 2023 Earnings Forecast  2023/05/02 03:00:18 ValueWalk
Key Points While it’s not a great strategy to make a bet on a stock when it’s close to reporting … Read more
   7 Growth Stocks With Huge Return Potential for Long-Term Investors  2023/04/25 20:55:49 InvestorPlace
Sooner or later, investors will stop fearing the “phantom recession,” i.e. the recession that really doesn’t exist except in many economists’ imaginations. At that point, many growth stocks should come soaring back. The latest evidence supporting my “phantom recession” theory came last week, when S&P reported that the U.S. private sector Purchasing Managers’ Index for April came in at 53.5 in April, up from 52.8 in March. Moreover, the nation’s Services PMI rose to 53.7, well above analysts’ average estimate of 51.5. Since services generate the lion’s share of U.S. economic output and the line between expansion and contraction among PMI stands at 50, the 53.7 reading indicates that the American economy is actually quite strong. That being said, and believing growth stocks will benefit from “phantom recession” realizations, here are some top stocks to consider. EVGO EVgo $5.80 BB BlackBerry $3.95 BNGO BioNano Genomics $0.74 CDNS Cadence Design Systems $203.40 ARRY Array Technologies $21.00 SCHW Charles Schwab $51.29 GM General Motors $32.93 EVgo ( EVGO ) Source: Sundry Photography / Shutterstock.com Electric vehicle charging company EVgo (NASDAQ: EVGO ) just reported a blowout fourth quarter.
   The 3 Best Renewable Energy Stocks to Invest in for a Rich Future  2023/04/23 16:43:42 InvestorPlace
It’s high time for investors to gain exposure to the best renewable energy stocks on the market. As the world races to mitigate the crippling impact of climate change, the demand for green energy sources is skyrocketing. Governments across the globe are effectively transitioning away from carbon-based fossil fuels to more sustainable alternatives. As we achieve our climate change objectives, the renewable energy sector’s growth is increasing at a breathtaking pace, with several companies ramping up production capabilities. The International Energy Agency projects that clean energy will account for a staggering 35% of the world’s electricity supply within a couple of years. The bulk of the increased electricity demand over the next few years will stem from China and other large Asian economies. Let’s delve deeper into the three best renewable energy stocks to invest in for a prosperous future. FSLR First Solar $216.89 BEPC Brookfield Renewable $45.94 ARRY Array Technologies $21.11 First Solar ( FSLR ) Source: IgorGolovniov / Shutterstock.com First Solar (NASDAQ: FSLR is a giant in the renewable energy realm, renowned for producing top-notch, thin-film solar panels boasting durability and efficiency.
   Array Technologies, Inc. Announces First Quarter 2023 Earnings Release Date and Conference Call  2023/04/18 20:05:00 GlobeNewswire
ALBUQUERQUE, N.M., April 18, 2023 (GLOBE NEWSWIRE) -- Array Technologies, Inc. (the “Company” or “Array”) (Nasdaq: ARRY) today announced that the company will release its first quarter 2023 results after the market close on Tuesday, May 9, 2023, to be followed by a conference call at 5:00 p.m. (Eastern Time) on the same day.
   Array Technologies Brings Solar Flare To 2023 Earnings Forecast  2023/05/02 03:00:18 ValueWalk
Key Points While it’s not a great strategy to make a bet on a stock when it’s close to reporting … Read more
   7 Growth Stocks With Huge Return Potential for Long-Term Investors  2023/04/25 20:55:49 InvestorPlace
Sooner or later, investors will stop fearing the “phantom recession,” i.e. the recession that really doesn’t exist except in many economists’ imaginations. At that point, many growth stocks should come soaring back. The latest evidence supporting my “phantom recession” theory came last week, when S&P reported that the U.S. private sector Purchasing Managers’ Index for April came in at 53.5 in April, up from 52.8 in March. Moreover, the nation’s Services PMI rose to 53.7, well above analysts’ average estimate of 51.5. Since services generate the lion’s share of U.S. economic output and the line between expansion and contraction among PMI stands at 50, the 53.7 reading indicates that the American economy is actually quite strong. That being said, and believing growth stocks will benefit from “phantom recession” realizations, here are some top stocks to consider. EVGO EVgo $5.80 BB BlackBerry $3.95 BNGO BioNano Genomics $0.74 CDNS Cadence Design Systems $203.40 ARRY Array Technologies $21.00 SCHW Charles Schwab $51.29 GM General Motors $32.93 EVgo ( EVGO ) Source: Sundry Photography / Shutterstock.com Electric vehicle charging company EVgo (NASDAQ: EVGO ) just reported a blowout fourth quarter.
   The 3 Best Renewable Energy Stocks to Invest in for a Rich Future  2023/04/23 16:43:42 InvestorPlace
It’s high time for investors to gain exposure to the best renewable energy stocks on the market. As the world races to mitigate the crippling impact of climate change, the demand for green energy sources is skyrocketing. Governments across the globe are effectively transitioning away from carbon-based fossil fuels to more sustainable alternatives. As we achieve our climate change objectives, the renewable energy sector’s growth is increasing at a breathtaking pace, with several companies ramping up production capabilities. The International Energy Agency projects that clean energy will account for a staggering 35% of the world’s electricity supply within a couple of years. The bulk of the increased electricity demand over the next few years will stem from China and other large Asian economies. Let’s delve deeper into the three best renewable energy stocks to invest in for a prosperous future. FSLR First Solar $216.89 BEPC Brookfield Renewable $45.94 ARRY Array Technologies $21.11 First Solar ( FSLR ) Source: IgorGolovniov / Shutterstock.com First Solar (NASDAQ: FSLR is a giant in the renewable energy realm, renowned for producing top-notch, thin-film solar panels boasting durability and efficiency.
   Array Technologies, Inc. Announces First Quarter 2023 Earnings Release Date and Conference Call  2023/04/18 20:05:00 GlobeNewswire
ALBUQUERQUE, N.M., April 18, 2023 (GLOBE NEWSWIRE) -- Array Technologies, Inc. (the “Company” or “Array”) (Nasdaq: ARRY) today announced that the company will release its first quarter 2023 results after the market close on Tuesday, May 9, 2023, to be followed by a conference call at 5:00 p.m. (Eastern Time) on the same day.
   Array Technologies: What''s Favorable, And What''s Not  2023/04/18 16:42:45 Seeking Alpha
The STI Norland acquisition should help derisk the business and expose Array to a promising Brazilian landscape. See why ARRY stock is a hold currently.
   Tuesday’s Top Analyst Upgrades and Downgrades: CarMax, Caterpillar, Cleveland-Cliffs, Eaton, First Solar, Medical Properties Trust, Paramount Global, Tesla and More – 24/7 Wall St.  2022/12/27 13:44:11 24/7 Wall street
Tuesday''s top analyst upgrades and downgrades included Array Technologies, CarMax, Caterpillar, Cleveland-Cliffs, Eaton, First Solar, Intercontinental Exchange, Medical Properties Trust, Paramount Global and Tesla.
   Array Technologies Shines on New Coverage  2022/12/23 20:00:28 TipRanks
Solar power could be a great idea in general. That’s giving stocks like solar installation company Array Technologies (NASDAQ:ARRY) a bit of an edg…
   Array Technologies rated Overweight in new coverage at Cantor Fitzgerald (NASDAQ:ARRY)  2022/12/23 15:39:48 Seeking Alpha
Array Technologies (ARRY) on Friday was rated Overweight in new coverage by analysts at Cantor Fitzgerald
   Cantor Fitzgerald Starts Array Technologies at Overweight  2022/12/23 11:19:01 Investing.com
https://www.investing.com/news/pro/cantor-fitzgerald-starts-array-technologies-at-overweight-432SI-2969687
   Array Technologies Inc. (NASDAQ: ARRY) Prices Could Rise In The Coming Months  2022/12/19 21:00:00 Marketing Sentinel
In the latest trading session, 0.76 million Array Technologies Inc. (NASDAQ:ARRY) shares changed hands as the company’s beta touched 0. With the company’s most recent per share price at $20.93 changed hands at -$0.84 or -3.86% at last look, the market valuation stands at $3.30B. ARRY’s current price is a discount, trading about -15.81% off … Array Technologies Inc. (NASDAQ: ARRY) Prices Could Rise In The Coming Months Read More »

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 アレイ・バイオファ―マ ARRY Array BioPharma Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)